Project Details
Description
Novartis CCTL019C2201; HM2015-13: A phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
| Status | Finished |
|---|---|
| Effective start/end date | 4/10/15 → 12/14/22 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.